Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Massive peripheral nerve hypertrophy in a patient with chronic inflammatory demyelinating polyradiculoneuropathy.
Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease.
[New challenges in multiple sclerosis treatment].
The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level-NO.
Measures of aging with disability in U.S. secondary data sets: Results of a scoping review.
Oligodendrocyte Development and Plasticity.
Characteristics of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Taking Injectable and Oral Disease Modifying Treatments (Dmt) In Europe (Eu).
MAL Overexpression Leads to Disturbed Expression of Genes That Influence Cytoskeletal Organization and Differentiation of Schwann Cells.
The epidemiology of alcohol consumption and multiple sclerosis: a review.
Amantadine: Multiple Sclerosis-Related Fatigue.
Characteristics in childhood and adolescence associated with future multiple sclerosis risk in men: cohort study.
[Vaccines and central nervous system demyelinating diseases: New studies on the internet –not just new rumors].
Cannabinoids: Medical implications.
Protective effect of cytosolic phospholipase A2 inhibition against inflammation and degeneration by promoting regulatory T cells in rats with experimental autoimmune encephalomyelitis.
(P150) assessment of acute and late toxicities of intracranial stereotactic radiosurgery in multiple sclerosis patients.
Axonal selection and myelin sheath generation in the central nervous system.
Quantitative MRI demonstrates abnormality of the fornix and cingulum in multiple sclerosis.
Computer-based cognitive exercises plus group classes for generalisation improved verbal memory and use of memory strategies by people with multiple sclerosis.
17β-estradiol replacement therapy protects myelin sheaths in the white matter of middle-aged female ovariectomized rats: a stereological study.
IgM-monoclonal gammopathy neuropathy and tremor: A first epidemiologic case control study.
Correlation between brain volume change and T2 relaxation time induced by dehydration and rehydration: Implications for monitoring atrophy in clinical studies.
Baseline MxA mRNA Expression Predicts Interferon Beta Response in Multiple Sclerosis Patients.
Simultaneous Determination of Oxysterols, Cholesterol and 25-Hydroxy-Vitamin D3 in Human Plasma by LC-UV-MS.
Detecting deoxyhemoglobin in spinal cord vasculature of the experimental autoimmune encephalomyelitis mouse model of multiple sclerosis using susceptibility MRI and hyperoxygenation.
A spectrum of inflammation and demyelinization in acute disseminated encephalomyelitis (ADEM) of children.
Pages
« first
‹ previous
…
521
522
523
524
525
526
527
528
529
…
next ›
last »